Abstract:Drug-induced liver injury (DILI) is one of the major concerns during drug development. Wide acceptance of the 3 R principles and the innovation of in-vitro techniques have introduced various novel model options, among which the three-dimensional (3D) cell spheroid cultures have shown a promising prospect in DILI prediction. The present study developed a 3D quadruple cell co-culture liver spheroid model for DILI prediction via self-assembly. Induction by phorbol 12-myristate 13-acetate at the concentration of 15.42 ng/mL for 48 hours with a following 24-hour rest period was used for THP-1 cell differentiation, resulting in credible macrophagic phenotypes. HepG2 cells, PUMC-HUVEC-T1 cells, THP-1-originated macrophages, and human hepatic stellate cells were selected as the components, which exhibited adaptability in the designated spheroid culture conditions. Following establishment, the characterization demonstrated the competence of the model in long-term stability reflected by the maintenance of morphology, viability, cellular integration, and cell-cell junctions for at least six days, as well as the reliable liver-specific functions including superior albumin and urea secretion, improved drug metabolic enzyme expression and CYP3A4 activity, and the expression of MRP2, BSEP, and P-GP accompanied by the bile acid efflux transport function. In the comparative testing using 22 DILI-positive and 5 DILI-negative compounds among the novel 3D co-culture model, 3D HepG2 spheroids, and 2D HepG2 monolayers, the 3D culture method significantly enhanced the model sensitivity to compound cytotoxicity compared to the 2D form. The novel co-culture liver spheroid model exhibited higher overall predictive power with margin of safety as the classifying tool. In addition, the non-parenchymal cell components could amplify the toxicity of isoniazid in the 3D model, suggesting their potential mediating role in immune-mediated toxicity. The proof-of-concept experiments demonstrated the capability of the model in replicating drug-induced lipid dysregulation, bile acid efflux inhibition, and α-SMA upregulation, which are the key features of liver steatosis and phospholipidosis, cholestasis, and fibrosis, respectively. Overall, the novel 3D quadruple cell co-culture spheroid model is a reliable and readily available option for DILI prediction.

Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

Three-dimensional Culture of Hepatocytes for Prediction of Drug-Induced Hepatotoxicity

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing

Development of novel tools for the in vitro investigation of drug-induced liver injury

Liver organoid as a 3D in vitro model for drug validation and toxicity assessment

Three-Dimensional Cell Co-Culture Liver Models and Their Applications in Pharmaceutical Research

Three-dimensional cell culture model for hepatocytes opens a new avenue of real world research on liver

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury

Toolbox for creating three-dimensional liver models

Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells

Application of 3D Hepatic Plate-Like Liver Model for Statin-Induced Hepatotoxicity Evaluation

Design and fabrication of an integrated 3D dynamic multicellular liver-on-a-chip and its application in hepatotoxicity screening

Current Advances on 3D‐Bioprinted Liver Tissue Models

Genetic toxicity assessment using liver cell models: past, present, and future

Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids

Advances in 3D Cell Culture for Liver Preclinical Studies.

A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration

Xeno-Free 3D Bioprinted Liver Model for Hepatotoxicity Assessment